v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue $ 1,002 $ 868
Cost of revenue 1,640 714
Contract loss adjustments (2,451)
Gross profit 1,813 154
Operating expenses:    
Research and development 14,090 6,679
General and administrative 14,092 4,520
Selling and marketing 643 359
Total operating expenses 28,825 11,558
Loss from operations (27,012) (11,404)
Other (expense) income:    
Interest income 517 301
Interest expense (9) (1,614)
Other expense (128) (61)
Change in fair value of warrant liabilities 26,555 46
Change in fair value of convertible promissory notes (87,824)
Change in fair value of long-term debt (2,470)
Total other expense (63,359) (1,328)
Loss before provision for income taxes (90,371) (12,732)
Provision for income taxes 48 1
Net Income (Loss) (90,419) (12,733)
Series A Preferred Stock dividends and accretion (1,417)
Net loss attributable to common stockholders $ (91,836) $ (12,733)
Net loss per share:    
Net loss per share basic $ (1.27) $ (0.18)
Net loss per share diluted $ (1.27) $ (0.18)
Weighted-average shares outstanding:    
Weighted-average shares outstanding Basic 72,421,272 70,947,705
Weighted-average shares outstanding diluted 72,421,272 70,947,705